Search for: "Dennis Mayo"
Results 61 - 80
of 182
Sorted by Relevance
|
Sort by Date
14 Jun 2013, 2:38 pm
By Dennis Crouch I asked a number of colleagues for their thoughts on the Supreme Court's recent Myriad Decision. [read post]
27 Feb 2019, 4:14 pm
by Dennis Crouch Hikma Pharmaceuticals USA Inc. v. [read post]
31 Aug 2018, 9:10 am
by Dennis Crouch A new petition for writ of certiorari focuses attention again on patent eligibility and the law-fact interplay. [read post]
30 Aug 2015, 5:52 pm
Invalid: Applying Mayo v. [read post]
6 Sep 2016, 5:03 pm
by Dennis Crouch Three eligibility cases are pending before the Supreme Court. [read post]
13 Sep 2016, 10:52 am
by Dennis Crouch McRO v. [read post]
28 Mar 2019, 9:07 am
by Dennis Crouch This case focuses on patents covering the opioid drug oxymorphone that Endo sells as Opana ER. [read post]
20 Aug 2016, 10:51 pm
The claims were therefore considered to be directed to ineligible subject matter under the standards established by the US Supreme Court in its Myriad and Mayo decisions. [read post]
30 Jan 2014, 8:48 am
By Dennis Crouch SmartGene v. [read post]
2 Aug 2010, 10:23 am
Mayo Collaborative Serv., 581 F.3d 1336, 1346 (Fed. [read post]
4 Sep 2015, 7:56 am
As Dennis Crouch notes, this seems like a straightforward application of Mayo - a non-inventive application of the natural phenomenon. [read post]
20 Jan 2016, 9:31 am
By Dennis Crouch On summary judgment, Judge Guilford (C.D.Cal) found Mortgage Grader’s asserted patents[1] ineligible under 35 U.S.C. [read post]
29 Apr 2018, 6:41 pm
by Dennis Crouch 01 Communique Lab. v. [read post]
27 Aug 2014, 7:41 am
by Dennis Crouch Planet Bingo v. [read post]
1 Aug 2016, 8:21 am
by Dennis Crouch In a short opinion, Judge Taranto has affirmed the lower court ruling that Electric Power Group’s asserted claims lacked subject matter eligibility. [read post]
26 Mar 2012, 8:31 am
by Dennis Crouch Retractable Techs., Inc. v. [read post]
5 Feb 2018, 7:30 am
By Dennis Crouch Ex parte Gerlitz, APPEAL 2017-002398, 2018 WL 619852 (PTAB Jan. 26, 2018) GlucoVista’s patent application claims a method of determining glucose concentration in a body (i.e., physical matter) by changing the body’s surface temperature and measuring the change in infrared (IR) radiation emitted at the wavelength associated with Glucose IR emissions. [read post]
9 Mar 2018, 7:44 am
by Dennis Crouch Exergen Corp. v. [read post]
20 Feb 2018, 2:04 am
by Dennis Crouch Ex Parte Simons, APPEAL 2016-002684 (Patent Tr. [read post]
15 Aug 2014, 2:27 pm
I am sure Dennis will do his usual full and grand treatment, but this one is sort of the counter-punch to Ultramercial. [read post]
